Default: OncoTargets and Therapy

ISSN:

Journal Home

Journal Guideline

OncoTargets and Therapy Q2 Unclaimed

Dove Medical Press Ltd. New Zealand
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

OncoTargets and Therapy is a journal indexed in SJR in Oncology and Pharmacology (medical) with an H index of 79. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 2079 €. The scope of the journal is focused on oncology, cancer, palliative care, therapeutic agents. It has an SJR impact factor of 0,836 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,836.

OncoTargets and Therapy focuses its scope in these topics and keywords: cancer, cell, lung, nonsmallcell, factor, growth, acid, significance, resistance, ovarian, ...

Type: Journal

Type of Copyright: CC BY-NC

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Price

2079 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

OncoTargets and Therapy

0,836

SJR Impact factor

79

H Index

131

Total Docs (Last Year)

2604

Total Docs (3 years)

6691

Total Refs

10352

Total Cites (3 years)

2601

Citable Docs (3 years)

3.88

Cites/Doc (2 years)

51.08

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


cancer, cell, lung, nonsmallcell, factor, growth, acid, significance, resistance, ovarian, nonsmall, nfkappab, induces, receptor, patients, signaling, colorectal, targeting, body, axispantioxidant, attenuates, arachidonic, oncology, cancer, palliative care, therapeutic agents

FAQS